Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD model

Area of Science:

• Oncology
• Mathematical Biology
• Pharmacokinetics

Background:

• Optimizing cancer chemotherapy requires balancing tumor cell reduction with host toxicity.
• Maintaining healthy cell populations, like white blood cells, is crucial during treatment.
• Drug delivery protocols significantly impact treatment efficacy and side effects.

Purpose of the Study:

• To develop an optimized drug delivery strategy for cancer chemotherapy using mathematical modeling.
• To minimize the final tumor cell count while preventing host toxicity.
• To identify a treatment protocol that maintains white blood cell counts above a critical threshold.

Main Methods:

• Utilized mathematical modeling and optimization techniques.
• Simulated tumor cell and white blood cell populations under various drug administration schedules.
• Minimized the objective function representing tumor cell load subject to toxicity constraints.

Main Results:

• The optimal chemotherapy strategy involves a specific sequence of drug administration.
• This includes an initial bolus dose, followed by a period without the drug.
• Subsequently, a continuous infusion phase is recommended to maintain normal cell limits and reduce tumor cells.

Conclusions:

• A precisely timed and sequenced drug administration protocol can enhance chemotherapy efficacy.
• Mathematical modeling provides a powerful tool for designing personalized and effective cancer treatment strategies.
• The proposed bolus-infusion strategy offers a promising approach to minimize toxicity and maximize tumor cell kill.